Skip to Main Content

Author Details

Terrence M Tumpey
Centers for Disease Control and Prevention.
1989
267
82
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37602528Pathogenesis and Transmission Assessment of 3 Swine-Origin Influenza A(H3N2) Viruses With Zoonotic Risk to Humans Isolated in the United States, 2017-2020.J Infect Dis2024
37981659Antibody-Mediated Suppression Regulates the Humoral Immune Response to Influenza Vaccination in Humans.J Infect Dis2024
36602361Utility of Human <i>In Vitro</i> Data in Risk Assessments of Influenza A Virus Using the Ferret Model.J Virol2023
37028126Enhanced fitness of SARS-CoV-2 B.1.617.2 Delta variant in ferrets.Virology2023
36690690Kinetics and magnitude of viral RNA shedding as indicators for Influenza A virus transmissibility in ferrets.Commun Biol2023
34985975Inherent Heterogeneity of Influenza A Virus Stability following Aerosolization.Appl Environ Microbiol2022
35840125Pathogenesis and Transmissibility of North American Highly Pathogenic Avian Influenza A(H5N1) Virus in Ferrets.Emerg Infect Dis2022
35537045Pathogenesis and transmission of human seasonal and swine-origin A(H1) influenza viruses in the ferret model.Emerg Microbes Infect2022
35684961Multiplex Detection of Antibody Landscapes to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/Influenza/Common Human Coronaviruses Following Vaccination or Infection With SARS-CoV-2 and Influenza.Clin Infect Dis2022
36448801Detection of Airborne Influenza A and SARS-CoV-2 Virus Shedding following Ocular Inoculation of Ferrets.J Virol2022
36366364Influenza A(H7N9) Pandemic Preparedness: Assessment of the Breadth of Heterologous Antibody Responses to Emerging Viruses from Multiple Pre-Pandemic Vaccines and Population Immunity.Vaccines (Basel)2022
36135377Comparative Assessment of Severe Acute Respiratory Syndrome Coronavirus 2 Variants in the Ferret Model.mBio2022
36056075Low quality antibody responses in critically ill patients hospitalized with pandemic influenza A(H1N1)pdm09 virus infection.Sci Rep2022
33531397Antibody Landscape Analysis following Influenza Vaccination and Natural Infection in Humans with a High-Throughput Multiplex Influenza Antibody Detection Assay.mBio2021
32449503Mammalian pathogenicity and transmissibility of low pathogenic avian influenza H7N1 and H7N3 viruses isolated from North America in 2018.Emerg Microbes Infect2020
31701647Identification of novel influenza A virus exposures by an improved high-throughput multiplex MAGPIX platform and serum adsorption.Influenza Other Respir Viruses2020
31654637A Guide for the Use of the Ferret Model for Influenza Virus Infection.Am J Pathol2020
32728042Characterization of highly pathogenic avian influenza H5Nx viruses in the ferret model.Sci Rep2020
32611751Genetically and Antigenically Divergent Influenza A(H9N2) Viruses Exhibit Differential Replication and Transmission Phenotypes in Mammalian Models.J Virol2020
30453209Historical and clinical aspects of the 1918 H1N1 pandemic in the United States.Virology2019
31430632Mammalian pathogenicity and transmissibility of a reassortant Eurasian avian-like A(H1N1v) influenza virus associated with human infection in China (2015).Virology2019
31201279Correction for Sun et al., "Risk Assessment of Fifth-Wave H7N9 Influenza A Viruses in Mammalian Models".J Virol2019
31312528Repeated vaccination against matched H3N2 influenza virus gives less protection than single vaccination in ferrets.NPJ Vaccines2019
30814288Tropism and Infectivity of a Seasonal A(H1N1) and a Highly Pathogenic Avian A(H5N1) Influenza Virus in Primary Differentiated Ferret Nasal Epithelial Cell Cultures.J Virol2019
31149353Heterologous prime-boost with A(H5N1) pandemic influenza vaccines induces broader cross-clade antibody responses than homologous prime-boost.NPJ Vaccines2019
30877121Swine-Origin H1 Influenza Viruses Isolated from Humans Exhibit Sustained Infectivity in an Aerosol State.Appl Environ Microbiol2019
30818793Sowing the Seeds of a Pandemic? Mammalian Pathogenicity and Transmissibility of H1 Variant Influenza Viruses from the Swine Reservoir.Trop Med Infect Dis2019
29321303Infection and Replication of Influenza Virus at the Ocular Surface.J Virol2018
30158292Comparative <i>In Vitro</i> and <i>In Vivo</i> Analysis of H1N1 and H1N2 Variant Influenza Viruses Isolated from Humans between 2011 and 2016.J Virol2018
29885769Multi-clade H5N1 virus-like particles: Immunogenicity and protection against H5N1 virus and effects of beta-propiolactone.Vaccine2018
30151584Infection of Cultured Mammalian Cells with Aerosolized Influenza Virus.Methods Mol Biol2018
29931203Influence of Immune Priming and Egg Adaptation in the Vaccine on Antibody Responses to Circulating A(H1N1)pdm09 Viruses After Influenza Vaccination in Adults.J Infect Dis2018
30177761Influenza virus infection causes global RNAPII termination defects.Nat Struct Mol Biol2018
30142572Importance of 1918 virus reconstruction to current assessments of pandemic risk.Virology2018
29848587Pathogenesis and Transmission of Genetically Diverse Swine-Origin H3N2 Variant Influenza A Viruses from Multiple Lineages Isolated in the United States, 2011-2016.J Virol2018
29949635Development of a high-throughput assay to detect antibody inhibition of low pH induced conformational changes of influenza virus hemagglutinin.PLoS One2018
30305359Risk Assessment of Fifth-Wave H7N9 Influenza A Viruses in Mammalian Models.J Virol2018
29477464The eyes have it: influenza virus infection beyond the respiratory tract.Lancet Infect Dis2018
29540597Antigenically Diverse Swine Origin H1N1 Variant Influenza Viruses Exhibit Differential Ferret Pathogenesis and Transmission Phenotypes.J Virol2018
29260672Mammalian Pathogenesis and Transmission of Avian Influenza A(H7N9) Viruses, Tennessee, USA, 2017.Emerg Infect Dis2018
29348212The 1918 flu, 100 years later.Science2018
27771560In vitro exposure system for study of aerosolized influenza virus.Virology2017
28100496Preexisting Immunity, Not Frailty Phenotype, Predicts Influenza Postvaccination Titers among Older Veterans.Clin Vaccine Immunol2017
28934461Effect of Priming With Seasonal Influenza A(H3N2) Virus on the Prevalence of Cross-Reactive Hemagglutination-Inhibition Antibodies to Swine-Origin A(H3N2) Variants.J Infect Dis2017
28934456Cross-Reactive Antibody Responses to Novel H5Nx Influenza Viruses Following Homologous and Heterologous Prime-Boost Vaccination with a Prepandemic Stockpiled A(H5N1) Vaccine in Humans.J Infect Dis2017
28934454Assessment of Molecular, Antigenic, and Pathological Features of Canine Influenza A(H3N2) Viruses That Emerged in the United States.J Infect Dis2017
28934452Pathogenesis, Transmissibility, and Tropism of a Highly Pathogenic Avian Influenza A(H7N7) Virus Associated With Human Conjunctivitis in Italy, 2013.J Infect Dis2017
29047426Airborne Transmission of Highly Pathogenic Influenza Virus during Processing of Infected Poultry.Emerg Infect Dis2017
29263871An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial.NPJ Vaccines2017
28515300A Novel A(H7N2) Influenza Virus Isolated from a Veterinarian Caring for Cats in a New York City Animal Shelter Causes Mild Disease and Transmits Poorly in the Ferret Model.J Virol2017
  • 1 - 50 of 267

Recommended Authors

Icahn School of Medicine at Mount Sinai New York
Career Start Year 2015
Number of shared co-authors 16
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2012
Number of shared co-authors 5
Institute of Virology, Freiburg University Medical Center, University of Freiburg
Career Start Year 2012
Number of shared co-authors 5
Campus de la Universitat Autonoma de Barcelona (UAB)
Career Start Year 2011
Number of shared co-authors 2
Icahn School of Medicine at Mount Sinai
Career Start Year 2011
Number of shared co-authors 17
Stanford University School of Medicine
Career Start Year 2010
Number of shared co-authors 2
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2010
Number of shared co-authors 9
University of Maryland
Career Start Year 2009
Number of shared co-authors 6
Icahn School of Medicine at Mount Sinai
Career Start Year 2009
Number of shared co-authors 10
Icahn School of Medicine at Mount Sinai
Career Start Year 2008
Number of shared co-authors 19
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 7
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 26
FluGen Inc.
Career Start Year 2007
Number of shared co-authors 9
Biodesign Center for Fundamental and Applied Microbiomics, Arizona State University
Career Start Year 2007
Number of shared co-authors 3
NYU Grossman School of Medicine
Career Start Year 2006
Number of shared co-authors 5
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 19
Influenza Research Institute, University of Wisconsin
Career Start Year 2006
Number of shared co-authors 22
University of California san francisco
Career Start Year 2006
Number of shared co-authors 8
National Center for Toxicological Research
Career Start Year 2005
Number of shared co-authors 22
College of Life Sciences, Inner Mongolia University
Career Start Year 2005
Number of shared co-authors 13
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 2004
Number of shared co-authors 13
Texas Biomedical Research Institute
Career Start Year 2001
Number of shared co-authors 20
Korea University College of Medicine
Career Start Year 2001
Number of shared co-authors 6
Infectious Disease Clinical Research Program, Uniformed Services University
Career Start Year 2000
Number of shared co-authors 3
Icahn School of Medicine at Mount Sinai
Career Start Year 2000
Number of shared co-authors 16
The University of North Carolina at Chapel Hill
Career Start Year 1998
Number of shared co-authors 23
Influenza Research Institute, University of Wisconsin-Madison
Career Start Year 1993
Number of shared co-authors 30
University of North Carolina at Chapel Hill
Career Start Year 1993
Number of shared co-authors 25
Erasmus Medical Center
Career Start Year 1986
Number of shared co-authors 11
University of Michigan School of Public Health ann arbor
Career Start Year 1959
Number of shared co-authors 10

Collaborators

Icahn School of Medicine at Mount Sinai
Co-authored papers 34
University of Washington
Co-authored papers 24
Vanderbilt University Medical Center
Co-authored papers 18
Icahn School of Medicine at Mount Sinai
Co-authored papers 17
Icahn School of Medicine at Mount Sinai
Co-authored papers 14
University of Washington
Co-authored papers 11
Fred Hutchinson Cancer Research Center
Co-authored papers 10
Icahn School of Medicine at Mount Sinai
Co-authored papers 8
Vanderbilt University Medical Center
Co-authored papers 7
Co-authored papers 6
University of Washington
Co-authored papers 4
Influenza Research Institute, University of Wisconsin
Co-authored papers 4
US Centers for Disease Control and Prevention
Co-authored papers 4
Co-authored papers 4
The Scripps Research Institute, USA The Skaggs Institute for Chemical Biology
Co-authored papers 4
College of Veterinary Medicine, Kansas State University
Co-authored papers 4
University of Chicago, Gwen Knapp Center for Lupus Research.
Co-authored papers 4
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 4
Ho Chi Minh City Pasteur Institute
Co-authored papers 3
Institut des Agents Infectieux, Infective Agents Institute, North Hospital Network
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Battelle Memorial Institute
Co-authored papers 3
Center for Vaccines and Immunology, University of Georgia
Co-authored papers 3
Pacific Northwest National Laboratory
Co-authored papers 2
University of Texas Medical Branch
Co-authored papers 2
Pacific Northwest National Laboratory
Co-authored papers 2
The Third People's Hospital of Da Lian
Co-authored papers 2
Sorbonne University INSERM
Co-authored papers 2
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 2